Evotec At BIO International Convention
State of the BioManufacturing Industry Roundtable
BioProcess Theater| Booth 5443
Date and Time: 5th June, 12:20pm – 1pm
Participant: Ninette van Lingen, SVP Business Development at Just-Evotec Biologics
Continuous Biomanufacturing for Increasing Access to Biologics
Insider Focus Panel and Presentation (10 minute case study and 30 minute panel)
Date and Time: 5th June
Presentation: 2:10pm – 2:20pm
Panel discussion: 2:30pm – 3pm
In a world where 6 billion people in low to middle income countries lack access to modern biopharmaceutical medicines, Just - Evotec Biologics has developed a continuous manufacturing platform that is reducing the production cost of antibody therapeutics below $50/gram. This innovative technology is incorporated in agile, small-footprint and sustainable J.POD production facilities. The concept has been validated by biosimilar-developer Sandoz who is working in partnership with Just - Evotec Biologics to increase patient access. Our presentation will explain how our unique technologies and business model have the potential to revolutionize the lives of patients irrespective of geography.
Presented by Jon Gunther, VP Business Development at Just- Evotec Biologics
Innovation & Trends in bioproduction
French Pavilion | Booth 3823
Date and Time: 5th June, 11am- 12am
Participants:
- Ninette van Lingen, SVP Business Development at Just-Evotec Biologics
- Lise Alter, Managing Director of the Health Innovation Agency
- Laurent Lafferrère, CEO of France BioLead
- Chloé Evans, Deputy Director General, Head of market research and international relations of France Biotech
